C.M. Thompson

Latest

• Production of virus-like particles for vaccination
• Recombinant protein production in large-scale agitated bioreactors using the baculovirus expression vector system
• Critical assessment of influenza VLP production in Sf9 and HEK293 expression systems
• Particle quantification of influenza viruses by high performance liquid chromatography
• Analytical technologies for influenza virus-like particle candidate vaccines: Challenges and emerging approaches